journal article·2017-01

Improved Anticancer Photothermal Therapy Using the Bystander Effect Enhanced by Antiarrhythmic Peptide Conjugated Dopamine‐Modified Reduced Graphene Oxide Nanocomposite

Jiantao Yu, Yu‐Hsin Lin, Lingyan Yang, Chih‐Ching Huang, Liliang Chen, Wen‐Cheng Wang, Guan‐Wen Chen, Junyan Yan, Saranta Sawettanun, Chia‐Hua Lin

Advanced Healthcare Materials· Volume 6· Issue 2
Publisher page

Abstract

Despite tremendous efforts toward developing novel near‐infrared (NIR)‐absorbing nanomaterials, improvement in therapeutic efficiency remains a formidable challenge in photothermal cancer therapy. This study aims to synthesize a specific peptide conjugated polydopamine‐modified reduced graphene oxide (pDA/rGO) nanocomposite that promotes the bystander effect to facilitate cancer treatment using NIR‐activated photothermal therapy. To prepare a nanoplatform capable of promoting the bystander effect in cancer cells, we immobilized antiarrhythmic peptide 10 (AAP10) on the surface of dopamine‐modified rGO (AAP10‐pDA/rGO). Our AAP10‐pDA/rGO could promote the bystander effect by increasing the expression of connexin 43 protein in MCF‐7 breast‐cancer cells. Because of its tremendous ability to absorb NIR absorption, AAP10‐pDA/rGO offers a high photothermal effect under NIR irradiation. This leads to a massive death of MCF‐7 cells via the bystander effect. Using tumor‐bearing mice as the model, it is found that NIR radiation effectively ablates breast tumor in the presence of AAP10‐pDA/rGO and inhibits tumor growth by ≈100%. Therefore, this research integrates the bystander and photothermal effects into a single nanoplatform in order to facilitate an efficient photothermal therapy. Furthermore, our AAP10‐pDA/rGO, which exhibits both hyperthermia and the bystander effect, can prevent breast‐cancer recurrence and, therefore, has great potential for future clinical and research applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics · Graphene research and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Nano‐Bio Interface Division of Nanobiomedicine Suzhou Institute of Nano‐Tech and Nano‐Bionics Chinese Academy of Sciences Suzhou 215123 China

Department of Food and Beverage Management Taipei College of Maritime Technology Taipei 11174 Taiwan

Institute of Bioscience and Biotechnology National Taiwan Ocean University Keelung 20224 Taiwan

The National Key Laboratory of Shock Wave and Detonation Physics Institute of Fluid Physics CAEP Mianyang 621900 China

Research Center for Environmental Changes Academia Sinica Taipei 11529 Taiwan

Department of Food Science National Taiwan Ocean University Keelung 20224 Taiwan

Department of Biotechnology National Formosa University Yunlin 63208 Taiwan

Funding

Ministry of Science and Technology, Taiwan

References (48)

Show source-provided references
1. Kong G. · Cancer Res. · 2001 · 61 · 3027
2. 10.1021/am508117e10.1021/am508117e ↗
3. 10.1039/c3tb21834a10.1039/c3tb21834a ↗
4. 10.1039/c2jm34330d10.1039/c2jm34330d ↗
5. 10.1002/lsm.190016020410.1002/lsm.1900160204 ↗
6. 10.1080/026567303100006504210.1080/0265673031000065042 ↗
7. 10.1002/smll.20130225210.1002/smll.201302252 ↗
8. 10.1039/c3nr01447a10.1039/c3nr01447a ↗
9. 10.1002/smll.20120310610.1002/smll.201203106 ↗
10. 10.1021/nn400647210.1021/nn4006472 ↗
11. 10.1002/smll.20110019110.1002/smll.201100191 ↗
12. 10.1002/adma.20100106810.1002/adma.201001068 ↗
13. 10.1021/jz101114310.1021/jz1011143 ↗
14. 10.2174/09298671179728754810.2174/092986711797287548 ↗
15. 10.1088/0957-4484/27/1/01570110.1088/0957-4484/27/1/015701 ↗
16. 10.1016/j.biomaterials.2014.02.03210.1016/j.biomaterials.2014.02.032 ↗
17. 10.1016/j.biomaterials.2015.01.07410.1016/j.biomaterials.2015.01.074 ↗
18. 10.1021/jp800977b10.1021/jp800977b ↗
19. 10.1021/jp710931h10.1021/jp710931h ↗
20. 10.1007/BF0145137610.1007/BF01451376 ↗
21. 10.1038/nnano.2009.5810.1038/nnano.2009.58 ↗
22. 10.1021/ma101526k10.1021/ma101526k ↗
23. 10.1039/c3ra43025a10.1039/c3ra43025a ↗
24. 10.1038/srep0468410.1038/srep04684 ↗
25. 10.1021/la102825p10.1021/la102825p ↗
26. 10.1073/pnas.223247910010.1073/pnas.2232479100 ↗
27. 10.1002/adma.20120468310.1002/adma.201204683 ↗
28. 10.1021/nn500722y10.1021/nn500722y ↗
29. 10.1021/acsami.5b0626510.1021/acsami.5b06265 ↗
30. 10.1038/nrc284110.1038/nrc2841 ↗
31. 10.1016/j.bbamem.2004.10.00110.1016/j.bbamem.2004.10.001 ↗
32. 10.1093/carcin/17.6.119910.1093/carcin/17.6.1199 ↗
33. 10.1038/nrc260310.1038/nrc2603 ↗
34. 10.3892/or.2015.410210.3892/or.2015.4102 ↗
35. 10.1002/wmts.7210.1002/wmts.72 ↗
36. 10.1002/mc.102610.1002/mc.1026 ↗
37. 10.1016/j.bbamem.2005.08.01210.1016/j.bbamem.2005.08.012 ↗
38. 10.1093/cvr/cvp02810.1093/cvr/cvp028 ↗
39. 10.1039/C2TB00025C10.1039/C2TB00025C ↗
40. 10.1021/nl071822y10.1021/nl071822y ↗
41. 10.1039/c2cc16890a10.1039/c2cc16890a ↗
42. 10.1021/cr400407a10.1021/cr400407a ↗
43. 10.1039/C4CC06849A10.1039/C4CC06849A ↗
44. 10.1016/j.biomaterials.2012.07.04010.1016/j.biomaterials.2012.07.040 ↗
45. 10.1016/j.carbon.2012.11.05810.1016/j.carbon.2012.11.058 ↗
46. 10.1016/j.carbon.2015.08.01710.1016/j.carbon.2015.08.017 ↗
47. 10.1016/j.biomaterials.2013.09.10810.1016/j.biomaterials.2013.09.108 ↗
48. 10.1016/j.radonc.2011.11.00210.1016/j.radonc.2011.11.002 ↗